Data Torturing, the Harms of Secondhand Smoking, and Why Disputing the Indisputable is Still Worth Our While by Judit Illes

“…Many of these advocates have also been revealed to have close ties with pharmaceutical companies that manufacture smoking cessation medications. …”
Get full text

CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care by Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB

“…Rachel Pullen, 1, 2 Marc Miravitlles, 3 Anita Sharma, 4 Dave Singh, 5 Fernando Martinez, 6 John R Hurst, 7 Luis Alves, 8, 9 Mark Dransfield, 10 Rongchang Chen, 11 Shigeo Muro, 12 Tonya Winders, 13 Christopher Blango, 14 Hana Muellerova, 15 Frank Trudo, 16 Paul Dorinsky, 17 Marianna Alacqua, 15, 18 Tamsin Morris, 19 Victoria Carter, 1, 2 Amy Couper, 1, 2 Rupert Jones, 20 Konstantinos Kostikas, 1, 21 Ruth Murray, 1 David B Price 1, 2, 22 1Observational and Pragmatic Research Institute, Singapore, Singapore; 2Optimum Patient Care, Cambridge, UK; 3Pneumology Dept, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 4Platinum Medical Centre, Chermside, QLD, Australia; 5Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK; 6New York-Presbyterian Weill Cornell Medical Center, New York, NY, USA; 7UCL Respiratory, University College London, London, UK; 8EPI Unit, Institute of Public Health, University of Porto, Porto, Portugal; 9Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal; 10Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA; 11Key Laboratory of Respiratory Disease of Shenzhen, Shenzhen Institute of Respiratory Disease, Shenzhen People’s Hospital (Second Affiliated Hospital of Jinan University, First Affiliated Hospital of South University of Science and Technology of China), Shenzhen, People’s Republic of China; 12Department of Respiratory Medicine, Nara Medical University, Nara, Japan; 13USA & Global Allergy & Airways Patient Platform, Vienna, Austria; 14Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, PA, USA; 15AstraZeneca, Cambridge, UK; 16AstraZeneca, Wilmington, DE, USA; 17AstraZeneca, Durham, NC, USA; 18CSL Behring SpA, Milan, Italy; 19AstraZeneca, Luton, UK; 20Research and Knowledge Exchange, Plymouth Marjon University, Plymouth, UK; 21Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece; 22Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UKCorrespondence: David B PriceCentre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UKTel +65 3105 1489Email dprice@opri.sgBackground: Chronic obstructive pulmonary disease (COPD) are managed predominantly in primary care. …”
Get full text

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT by Emmanuelle Papot, Simone Jacoby, Dona Arlinda, Anchalee Avihingsanon, Iskandar Azwa, Margaret Borok, Dannae Brown, Mohamed Cissé, Sounkalo Dao, Nnakelu Eriobu, Richard Kaplan, Muhammad Karyana, Nagalingeswaran Kumarasamy, Johnnie Lee, Marcelo H. Losso, Gail V. Matthews, Leonardo Perelis, Carmen Perez-Casas, Kiat Ruxrungtham, Melynda Watkins, H. Clifford Lane, Anthony Kelleher, Matthew Law, Mark N. Polizzotto

Get full text

The route to well-being at workplace: examining the role of job insecurity and its antecedents by Sumera Saeed, Ibne Hassan, Ghulam Dastgeer, Tehrim Iqbal

“…Design/methodology/approach – A sample of 306 salespersons of pharmaceutical companies working in Pakistan was obtained. …”
Get full text

Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF by Yun-Jeong Song, In Ah. Choi, Françoise Meylan, M. Kristen Demoruelle, Taylor Farley, Arianne C. Richard, Eric Hawley, John Botson, Yoo Jin Hong, Eun Young Lee, Sabina R. Mian, Bartlett C. Hamilton, Geoffrey M. Thiele, Ted R. Mikuls, Naveen Gara, Chris D. Ward, Sarah Lamberth, Kevin D. Deane, Theo Heller, Michael M. Ward, David M. Lee, Thi-Sau Migone, William Stohl, James R. O’Dell, Jill M. Norris, V. Michael Holers, Peter Gregersen, Yeong-Wook Song, Richard M. Siegel

Get full text

Nicotine vaccines for smoking cessation. by Hartmann-Boyce, J, Cahill, K, Hatsukami, D, Cornuz, J

“…All were smoking cessation trials conducted by pharmaceutical companies as part of the drug development process, and all trials were judged to be at high or unclear risk of bias in at least one domain. …”

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. by Macritchie, K, Geddes, J, Scott, J, Haslam, DR, Goodwin, G

“…Authors, other experts in the field and pharmaceutical companies were contacted for knowledge of suitable published or unpublished trials. …”

Undisclosed Surgical Incentives Compromise Informed Consent by Randi Belisomo

“…When disclosure is required in cases in which an outside commercial entity may profit, such as pharmaceutical companies, patients are made better aware of any reason outside of his or her best medical interest for which he or she may be prescribed a drug. …”
Get full text

A QSAR approach for virtual screening of lead-like molecules en route to antitumor and antibiotic drugs from marine and microbial natural products by Florbela Pereira, Diogo A. R. S. Latino

“…This rate is approximately 1.7- to 3.3-fold better than the industry average (1 in 5,000–10,000 tested compounds).4 Nowadays, there are facilities for high-throughput screening available both in academic labs or in pharmaceutical companies, but the cost of random screening for collections with a high number of compounds can nevertheless be prohibitive, making chemoinformatics approaches for virtual screening of the most probable active compounds valuable tools. …”
Get full text

Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas by Nick A. Kuburich, Petra den Hollander, Maria Castaneda, Mika Pietilä, Ximing Tang, Harsh Batra, Francisco Martínez-Peña, Tanvi H. Visal, Tieling Zhou, Breanna R. Demestichas, Ritesh V. Dontula, Jojo Y. Liu, Joanna Joyce Maddela, Reethi S. Padmanabhan, Lan Thi Hanh Phi, Matthew J. Rosolen, Thiru Sabapathy, Dhiraj Kumar, Filippo G. Giancotti, Luke L. Lairson, Maria Gabriela Raso, Rama Soundararajan, Sendurai A. Mani

Get full text

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases by Goran Bjelakovic, Dimitrinka Nikolova, Lise Lotte Gluud, Rosa G. Simonetti, Christian Gluud

“…We scanned bibliographies of relevant publications and asked pharmaceutical companies for additional trials. Selection criteria: We included all primary and secondary prevention randomized clinical trials on antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, and selenium) versus placebo or no intervention. …”
Get full text

<p align="justify">The Strategic Management and the Illegality: a case study on the fighting against piracy in Brazil<br><br>A Gestão Estratégica e a Ilegalidade: um estudo de caso... by MACHADO, Solange Mata, MELLO, Rodrigo Bandeira de

“…To study this phenomenon, three multinational pharmaceutical companies suffering from illegality were investigated. …”
Get full text

3545 “Sofia Learns about Research”: an interactive storybook to educate children and their families on clinical research with a welcoming and inclusive approach. by Teresa Quattrin, Renee Cadzow, Alex Marrone, Terry-Ann Smith, Briana Getman

“…To our knowledge most of the materials explaining research to children are geared to older children and are often sponsored by pharmaceutical companies for a specific trial. If successful, this book can have a profound impact in reaching out to children outside of the research and medical environments, with the ultimate goal of increasing the child’s and family’s willingness to participate in clinical research and clinical trials.…”
Get full text

Topiramate for acute affective episodes in bipolar disorder in adults by Pigott, K, Galizia, I, Vasudev, K, Watson, S, Geddes, J, Young, A

“…This is an update of a previous Cochrane review (last published 2006) on the role of topiramate in bipolar disorder.To assess the effects of topiramate for acute mood episodes in bipolar disorder in adults compared to placebo, alternative pharmacological treatment, and combination pharmacological treatment as measured by treatment of symptoms on specific rating scales for individual episodes.We searched the Cochrane Depression, Anxiety and Neurosis Controlled Trials Register to 13 October 2015, which includes records from the Cochrane Central Register of Controlled Trials (CENTRAL) all years; MEDLINE 1950-; EMBASE 1974-; and PsycINFO 1967-.We performed handsearching, reviewing of grey literature and reference lists, and correspondence with authors and pharmaceutical companies.Randomised controlled trials comparing topiramate with placebo or with active agents in the treatment of acute mood episodes in adult male and female patients with bipolar disorder.Two review authors independently performed data extraction and methodological quality assessment. …”

Antidepressants versus placebo for panic disorder in adults by Bighelli, I, Castellazzi, M, Cipriani, A, Girlanda, F, Guaiana, G, Koesters, M, Turrini, G, Furukawa, TA, Barbui, C

“…Limitations in results include funding of some studies by pharmaceutical companies, and only assessing short-term outcomes. …”

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. by Cipriani, A, Reid, K, Young, A, Macritchie, K, Geddes, J

“…Reference lists of relevant papers and previous systematic reviews were handsearched. Pharmaceutical companies marketing valproate and experts in this field were contacted for supplemental data. …”

台灣民族藥學知識及其保護 Ethno-pharmacological Knowledge of Taiwan and its Protection by 郭華仁 Warren H. J. Kuo, 嚴新富 Jau-Hwa Chen, 陳昭華 Hsin-Fu Yen, 鴻義章 Antonio I. C. Hong

“…For this reason, many pharmaceutical companies are engaged in bioprospecting. However, cost of bioprospecting is fairly expensive. …”
Get full text

Journal of Health and Social Sciences: A reputable, DOAJ-indexed, free, open access journal by Francesco Chirico

“…In addition, JHSS has not received any economic support from public or economic institutions or pharmaceutical companies. JHSS is pure because it is free of any political or economic pressures; it is propelled by highly passionate, enthusiastic, competent contributing researchers and their tireless work. …”
Get full text

Etanercept for the treatment of rheumatoid arthritis. by Lethaby, A, Lopez-Olivo, M, Maxwell, L, Burls, A, Tugwell, P, Wells, G

“…The trials were generally of moderate to low risk of bias, the majority funded by pharmaceutical companies. Follow-up ranged from six months to 36 months.BenefitAt six to 36 months the American College of Rheumatology (ACR) 50 response rate was statistically significantly improved with etanercept plus DMARD treatment when compared with a DMARD in those people who had an inadequate response to any traditional DMARD (risk ratio (RR) 2.0; 95% confidence interval (CI) 1.3 to 2.9, absolute treatment benefit (ATB) 38%; 95% CI 13% to 59%) and in those people who were partial responders to MTX (RR 11.7; 95% CI 1.7 to 82.5, ATB 36%). …”

Development of Pharmaceutical Supply Chain Agility Model using an Interpretive Structural Modeling (ISM) Approach by Adel Azar, Amir Khorrami

“…Therefore, most pharmaceutical companies try to store a large volume of inventory to ensure 100% accountability (Chandrasekaran & Kumar, 2003).MethodologyThis study aims to present a model for the interactions of pharmaceutical SCA factors. …”
Get full text